Sercan Aksoy - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sercan Aksoy

Showing results (151-160 of 206) with videos related to

Pageof 21

Sort By:

Current Oncology (Toronto, Ont.)|November 24, 2023

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency AnemiaBurak Yasin Aktaş, Emine Büşra Ata, Engin Çeşmeci, et al.

BMJ Supportive & Palliative Care|September 4, 2021

Sarcopenia and anthracycline cardiotoxicity in patients with cancerOnur Bas, Ahmet Gurkan Erdemir, Mehmet Ruhi Onur, et al.

Current Medical Research and Opinion|November 8, 2016

Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective studyNebi Serkan Demirci, Sercan Aksoy, Nuriye Yıldırım Özdemir, et al.

Tumori|May 9, 2015

Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancerTaner Babacan, Orhan Efe, Ahmet S Hasirci, et al.

Journal of the National Medical Association|May 30, 2008

Characteristics of breast cancer patients with central nervous system metastases: a single-center experienceHakan Harputluoglu, Omer Dizdar, Sercan Aksoy, et al.

Biorxiv : the Preprint Server for Biology|September 25, 2023

Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancerMustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, et al.

European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 24, 2022

The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinomaDeniz Can Guven, Enes Erul, Feride Yilmaz, et al.

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 11, 2021

Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better?Oktay Halit Aktepe, Fadime Sinem Ardic, Deniz Yuce, et al.

Medical Oncology (Northwood, London, England)|May 17, 2011

Outcome of non-metastatic male breast cancer: 118 patientsUlkü Yalçıntaş Arslan, Berna Oksüzoğlu, Nuriye Ozdemir, et al.

BMC Cancer|November 29, 2025

Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experienceOnur Baş, Bediz Kurt İnci, İmdat Eroğlu, et al.

Pageof 21

Search research articles

Showing results (151-160 of 206) with videos related to

Sort By:

Pageof 21

Current Oncology (Toronto, Ont.)|November 24, 2023

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency AnemiaBurak Yasin Aktaş, Emine Büşra Ata, Engin Çeşmeci, et al.

BMJ Supportive & Palliative Care|September 4, 2021

Sarcopenia and anthracycline cardiotoxicity in patients with cancerOnur Bas, Ahmet Gurkan Erdemir, Mehmet Ruhi Onur, et al.

Current Medical Research and Opinion|November 8, 2016

Tumori|May 9, 2015

Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancerTaner Babacan, Orhan Efe, Ahmet S Hasirci, et al.

Journal of the National Medical Association|May 30, 2008

Characteristics of breast cancer patients with central nervous system metastases: a single-center experienceHakan Harputluoglu, Omer Dizdar, Sercan Aksoy, et al.

Biorxiv : the Preprint Server for Biology|September 25, 2023

Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancerMustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, et al.

The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinomaDeniz Can Guven, Enes Erul, Feride Yilmaz, et al.

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 11, 2021

Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better?Oktay Halit Aktepe, Fadime Sinem Ardic, Deniz Yuce, et al.

Medical Oncology (Northwood, London, England)|May 17, 2011

Outcome of non-metastatic male breast cancer: 118 patientsUlkü Yalçıntaş Arslan, Berna Oksüzoğlu, Nuriye Ozdemir, et al.

BMC Cancer|November 29, 2025

Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experienceOnur Baş, Bediz Kurt İnci, İmdat Eroğlu, et al.

Pageof 21